These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38263084)
1. Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor). Zhang L; Chen J; Yang X; Shen C; Huang J; Zhang D; Liu N; Liu C; Zhong Y; Chen Y; Tang K; Guo J; Cui T; Duan S; Li J; Huang S; Pan H; Zhang H; Tang X; Chang Y; Gao Y Signal Transduct Target Ther; 2024 Jan; 9(1):20. PubMed ID: 38263084 [TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease. Xu S; Kong L; Li L; Wang C; Gu J; Luo H; Meng Q Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166930. PubMed ID: 37918680 [TBL] [Abstract][Full Text] [Related]
3. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway. Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397 [TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1. Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978 [TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. Wree A; McGeough MD; Peña CA; Schlattjan M; Li H; Inzaugarat ME; Messer K; Canbay A; Hoffman HM; Feldstein AE J Mol Med (Berl); 2014 Oct; 92(10):1069-82. PubMed ID: 24861026 [TBL] [Abstract][Full Text] [Related]
6. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471 [TBL] [Abstract][Full Text] [Related]
7. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. Wan X; Xu C; Lin Y; Lu C; Li D; Sang J; He H; Liu X; Li Y; Yu C J Hepatol; 2016 Apr; 64(4):925-32. PubMed ID: 26639394 [TBL] [Abstract][Full Text] [Related]
8. Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis. Kaufmann B; Kui L; Reca A; Leszczynska A; Kim AD; Booshehri LM; Wree A; Friess H; Hartmann D; Broderick L; Hoffman HM; Feldstein AE Cell Mol Gastroenterol Hepatol; 2022; 14(4):751-767. PubMed ID: 35787975 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis. Qin W; Weng J Sci Bull (Beijing); 2023 Jul; 68(13):1413-1429. PubMed ID: 37336688 [TBL] [Abstract][Full Text] [Related]
10. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933 [TBL] [Abstract][Full Text] [Related]
11. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation. Sui YH; Luo WJ; Xu QY; Hua J World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141 [TBL] [Abstract][Full Text] [Related]
12. Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway. Yang F; Lv XT; Lin XL; Wang RH; Wang SM; Wang GE Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1961-1971. PubMed ID: 37997375 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322 [TBL] [Abstract][Full Text] [Related]
14. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance. Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886 [TBL] [Abstract][Full Text] [Related]
15. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334 [TBL] [Abstract][Full Text] [Related]
16. Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice. Zhu JY; Chen M; Mu WJ; Luo HY; Guo L Metabolism; 2022 Sep; 134():155241. PubMed ID: 35750235 [TBL] [Abstract][Full Text] [Related]
17. Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model. Sun K; Wang J; Lan Z; Li L; Wang Y; Li A; Liu S; Li Y Obes Surg; 2020 Sep; 30(9):3435-3443. PubMed ID: 32266697 [TBL] [Abstract][Full Text] [Related]
18. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice. Yu Y; Chen D; Zhao Y; Zhu J; Dong X Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601 [TBL] [Abstract][Full Text] [Related]
19. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury. Han CY; Rho HS; Kim A; Kim TH; Jang K; Jun DW; Kim JW; Kim B; Kim SG Cell Rep; 2018 Sep; 24(11):2985-2999. PubMed ID: 30208322 [TBL] [Abstract][Full Text] [Related]
20. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Wu L; Liu Y; Zhao Y; Li M; Guo L Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]